NOTE 14 – SUBSEQUENT EVENTS

On July 4, 2025, the U.S. enacted H.R. 1 “A bill to provide for reconciliation pursuant to Title II of H. Con. Res. 14.” The bill contains a broad range of tax reform provisions affecting businesses. The Company is currently evaluating the full effects of the legislation on the Company's estimated annual effective tax rate and deductibility of certain R&D expenses. As the legislation was signed into law after June 30, 2025, the impacts are not reflected in the Company's operating results for the three and six months ended June 30, 2025.

On August 6, 2025, the Compensation Committee of the Board of Directors approved a grant of 51,250 options with the total value of $87,907 to the members of the Technical Advisory Board. The options had an exercise price of $2.04 per share, which shall be amortized on a straight-line basis over the vesting period into stock-based compensation expenses within the Statement of Comprehensive Loss. The options were granted under the 2025 Plan and vest in five monthly installments starting on August 6, 2025, with some options having a cliff vesting provision.